✦ LIBER ✦

Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

✍ Scribed by Hamilton, Betty Ky; Rybicki, Lisa; Gerds, Aaron; Hanna, Rabi; Sobecks, Ronald; Duong, Hien; Starn, Jamie; Corbett, Elaina; Bolwell, Brian; Majhail, Navneet S.; Kalaycio, Matt E.

Book ID: 122285067
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 110 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.383

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Novel 5-Group Cytogenetic Risk Class

The Novel 5-Group Cytogenetic Risk Classification of Myelodysplastic Syndrome (MDS), Monosomal Karyotype, and Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ A. Gerds; T. Gooley; B.L. Scott; F.R. Appelbaum; H.J. Deeg 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Evaluation Of Patients With Myelodysplas

Evaluation Of Patients With Myelodysplastic Syndrome (MDS) Up To Age Seventy-Five, Referred For Allogeneic Hematopoietic Cell Transplant (HCT) Including Donor Availability And HCT Outcomes

✍ T.L. Field; J. Perkins; J. Kim; M.A. Kharfan-Dabaja; H.F. Fenandez; L. Perez; J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Salvage allogeneic stem cell transplanta

Salvage allogeneic stem cell transplantation in patients with pediatric myelodysplastic syndrome and myeloproliferative neoplasms

✍ Kato, Motohiro; Yoshida, Nao; Inagaki, Jiro; Maeba, Hideaki; Kudo, Kazuko; Cho, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Improved Outcome After Reduced Intensity

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (RI-HCT) For MDS Using Tacrolimus/Sirolimus As GVHD Prophylaxis

✍ R. Nakamura; J. Palmer; J. Chao; T. Stiller; V. Pullarkat; P. Parker; A. Stein; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

278: Treosulfan Plus Fludarabine for All

278: Treosulfan Plus Fludarabine for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Leukemia and Myelodysplastic Syndrome

✍ E.R. Nemecek; B. Ly; T. Kovacsovics; R.T. Maziarz; J. Baumgart; J.E. Sanders; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Pre-Transplant Azacitidine and Allogenei

Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients up to Age Seventy-Five with Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

✍ Field, Teresa; Perkins, Janelle; Hillgruber, Ryan; Nishihori, Taiga; Tomblyn, Ma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 71 KB